Angle Glaucoma News Today

Another Federal Reserve meeting relatively unscathed but still need to face the uks big vote on whether to leave the european union. Fed agreed to do nothing and that keeps stocks on the agenda the place to get the short term for your money. The stock market rallied on the news as we sold off later in the day after oil plunged a dollar dow sinking 35 points s p slipping 0. 1 and nasdaq climbed by the same amount. Still, i was pleased to hear that the fed paid no attention to the idealogues who w...

World Glaucoma Day is observed annually on March 12th. This day is dedicated to raising awareness about glaucoma, a group of eye conditions that can lead to optic nerve damage and vision loss. Glaucoma often develops gradually and is characterized by increased pressure in the eyes, which can damage the optic nerve. Read on to know symptoms, myths and misconceptions, and preventive measures. , Health News, Times Now

Increasing research and innovation in various treatment options will drive demand for glaucoma treatment....

Glaucoma is a group of eye diseases that can cause blindness and we bring you ways in which the family, primary caregiver and counsellors can adopt to provide better care to loved ones with this condition.  

Glioblastoma Pipeline Analysis: 60+ Key Pipeline Therapies and 60+ Key Pharma Players are Looking Out in the Glioblastoma Pipeline Landscape iCrowd Newswire DelveInsights Glioblastoma Pipeline Insight report offers a detailed overview of the pipeline therapies that are in various clinical and preclinical stages of growth, as well as their launch and how the market is expected to change as a result across the Glioblastoma domain. For Glioblastoma emerging drugs, the Glioblastoma Pipeline Analysi...

Share this article Share this article ResearchAndMarkets.coms offering. This report describes and evaluates the global antiglaucoma drugs market. It covers 2015 to 2019, termed the historic period, and 2019 to 2023 termed the forecast period, along with further forecasts for the periods 2023-2025 and 2025-2030. The global antiglaucoma drugs market reached a value of nearly $6,591.8 million in 2019, having increased at a compound annual growth rate (CAGR) of 4.2% since 2015. The market is expec...